PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system and has high morbidity and mortality rates. It is essential to search new biomarkers to improve the accuracy of early HCC diagnosis. Therefore, we evaluated the diagnostic value of prothromb...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Honglei, Li, Bole, Li, Ze, Wei, Qian, Ren, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045263/
https://www.ncbi.nlm.nih.gov/pubmed/33849479
http://dx.doi.org/10.1186/s12885-021-08138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045263/
https://www.ncbi.nlm.nih.gov/pubmed/33849479
http://dx.doi.org/10.1186/s12885-021-08138-3

Ejemplares similares